Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Cuscuta reflexa extracts and an isolate promoted hair growth and could be natural treatments for hair loss.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Hirsutism causes significant psychological distress in women.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

SHBG may be a useful early indicator and treatment target for PCOS.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.